Selective activation VDR – pioneering approach to prevention and treatment of secondary hyperpara-thyreoidism, cardio- and renoprotecton


V.Yu. Shilo

Faculty of Post diploma Additional Education State Educational Institution of High Professional Education Moscow State Medical Stomatological University, Moscow
Discuss innovative approaches to the treatment of secondary hyperparathyroidism in chronic kidney disease with celektivnyh receptor activator of vitamin D.

About the Autors


Shilo V.Yu. – medical director B. Braun Avitum Russland Clinics, associate professor at nephrology department at Faculty of Post diploma Additional Education State Educational Institution of High Professional Education Moscow State Medical Stomatological University, Ph.D.
E-mail: nephrolog@gmail.com


Similar Articles


Бионика Медиа